Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E.coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.